This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Type 2 Diabetes
and you are
between 18 and 80
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added to metformin monotherapy in patients with type 2 diabetes.

Provided treatments

  • Drug: ITCA 650 60 mcg/day
  • Drug: sitagliptin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01455909. The sponsor of the trial is Intarcia Therapeutics and it is looking for 0 volunteers for the current phase.
Official trial title:
A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes